A prospective single arm trial included 14 refractory HLH/MAS patients who did not respond to high-dose corticosteroid treatment (with or without combination with anakinra), and all clinical and laboratory parameters showed rapid improvement after receiving anti IFN-γ treatment [152]. The gene discussed is IFNG; the disease is hemophagocytic syndrome.